COVID-19 laboratory biosafety guide

Laboratory-associated infections and biosafety.

An estimated 500,000 laboratory workers in the United States are at risk of exposure to infectious agents that cause disease ranging from inapparent to life-threatening infections, but the precise risk to a given worker unknown. The emergence of human immunodeficiency virus and hantavirus, the continuing problem of hepatitis B virus, and the reemergence of Mycobacterium tuberculosis have renewe...

Biosafety Issues in Laboratory Research

Dioxins is a compound family among persistent organic pollutants toxics produced by industrial wastes. 2,3,7,8-Tetrachlorodibenzo -p-dioxin (TCDD) is a typical representative of dioxins, which not only exhibits systemic carcinogenicity, teratogenicity, immunotoxicity, hepatotoxicity, endocrine disruption and waste syndrome to humans, but also has effects on physiology and pathology of human ski...

The role of laboratory parameters in COVID-19 diagnosis

Good laboratory practices guarantee biosafety in the Sierra Leone-China friendship biosafety laboratory

BACKGROUND The outbreak of Ebola virus disease (EVD) in West Africa between 2014 and 2015 was the largest EDV epidemic since the identification of Ebola virus (EBOV) in 1976, and the countries most strongly affected were Sierra Leone, Guinea, and Liberia. FINDINGS The Sierra Leone-China Friendship Biological Safety Laboratory (SLE-CHN Biosafety Lab), a fixed Biosafety Level 3 laboratory in th...

Assessment of Clinical and Laboratory Data among the Readmitted COVID-19 and Non COVID-19 Patients in Iran

Background and Objective: Hospital readmissions are common and expensive. Identifying the patients who are at high risk of readmission can decrease readmission. Hence, in the present study, the clinical characteristics, biomarker results, and Computed Tomography (CT) criteria of all the readmitted patients were assessed. Materials and Methods: Data of 98 readmitted patients to the Baqiyatallah...